[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital World Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 1,378,399,660 6 SHARED ]
[JOINT FILING AGREEMENT Dated: February 14, 2019 CANTILLON CAPITAL MANAGEMENT LLC Kevin S. Aarons CANTILLON MANAGEMENT L.P. Kevin S. Aarons CANTILLON INC. Kevin S. Aarons WILLIAM VON MUEFFLING EX-99.1 2 c27889211b.htm JOINT FILING AGREEMENT] [IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ]
[1. NAMES OF REPORTING PERSONS Luxor Capital Partners, LP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [x] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER]
[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital World Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 1,378,399,660 6 SHARED ]
[JOINT FILING AGREEMENT Rule 13d-1(k) under In accordance with the requirements of This agreement may be executed in any number of counterparts, each of which shall be deemed an original. EXECUTED this 14th day of February, 2019. Altaba Inc. Thomas J. McInerney Thomas J. McInerney Chief Executive Off]
[SCHEDULE 13G/A Amendment No. 14 Global Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *]
[JOINT FILING AGREEMENT Rule 13d-1(k) under In accordance with the requirements of This agreement may be executed in any number of counterparts, each of which shall be deemed an original. EXECUTED this 14th day of February, 2019. Altaba Inc. Thomas J. McInerney Thomas J. McInerney Chief Executive Off]
[SCHEDULE 13G/A Amendment No. 14 Global Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *]
[Joint Filing Agreement 13d-1(k) In accordance with Rule [Remainder of this page has been left intentionally blank.] 16 Sheng Chen Sheng Chen Fast Horse Technology Limited Sheng Chen Director Sunrise Corporate Holding Ltd. Sheng Chen Director Personal Group Limited Sheng Chen Director Beacon Capital ]
[Joint Filing Agreement 13d-1(k) In accordance with Rule [Remainder of this page has been left intentionally blank.] 16 Sheng Chen Sheng Chen Fast Horse Technology Limited Sheng Chen Director Sunrise Corporate Holding Ltd. Sheng Chen Director Personal Group Limited Sheng Chen Director Beacon Capital ]
